Thyroid Disorders Flashcards
Function of the Thyroid
-Iodine uptake
-Thyroglobulin production
- Hormone secretion
T3 (triiodothyronine) T4 (thyroxine)
- Metabolism
- Temperature homeostasis
- Heart rate
- Body Tissue
Growth
Development
Function
Maintenance
Thyroid Physiology
- Iodide transported into thyroid cell
- Thyroid peroxidase oxidizes iodide
- Binds to iodinated tyrosine residue on thyroglobulin
- Combine to form iodothyronines
Thyroxine (T4) (80%) Triiodothyronine (T3) (20%) Triiodothyronine (IT3) (inactive) - T4 further breakdown to produce majority of T3
T3 and T4 Thyroid Hormones
- T3 and T 4 are secreted to the thyroid cell cytoplasm via exocytosis and then cross the capillary membranes into the blood stream
- 99.8% (T3) and 99.98% (T4) plasma protein bound
Albumin
Thyroxine-binding globulin (TBG)
Tranthyretin - Only free hormone is physiologically active
Thyroid Function Tests
Free T4- 0.8- 2.7 Free T3- 230- 420 Total T4- 4.8- 10.4 Total T3- 60- 181 TSH- 0.4- 4
Hyperthyroidism Disorders
Graves’ Disease
Multi-nodular Toxic Goiter (Plummer’s Disease)
Thyrotoxicosis
Hypothyroidism Disorders
Primary Hashimoto’s thyroiditis Iatrogenic Secondary Pituitary disease Hypothalamic disease
Drugs Affecting Serum TGB
↑ Serum thyroxine binding globulin (TGB) Estrogen Tamoxifen Heroin Methadone Mitotane Fluorouracil
↓ Serum thyroxine binding globulin(TBG) Androgens Anabolic steroids Slow release nicotinic acid Glucocorticoids
Drugs that Decrease TSH secretion
Dopamine
Glucocorticoids
Octreotide
Drugs that decrease Thyroid Secretion
Lithium
Iodide and iodine preparations
Radiocontrast dyes
Amiodarone - Can ↑↓ Thyroid hormone secretion
Epidemiology of Hyperthyroidism
Peak incidence between 40-60 years old More common in women 1:5 -1:10 (Male:Female) Prevalence: 0.5% in United States 60-80% is Graves’ Disease
Graves Disease
Stimulating TSH receptor antibody (TSH-R stim) causes excessive TSH production
Multinodular Goiter
Becomes thyrotoxic without ab due to exogenous iodine administration
Nodule become autonomous
Tumors or adenomas
Causes of Goiter
due to organic (KI) or inorganic (amiodarone) sources
- thyroid nodule goes rogue from TSH regulation and synthesizes excess T4
Signs/Symptoms of Hyperthyroidism
Nervousness Palpitations/↑HR Irritability Fatigue Menstrual disturbances Heat intolerance Weight loss with increase in appetite Flushed moist skin Exophthalmos/ Proptosis (Graves’ disease) Thinning hair Enlarged thyroid Brittle nails
Diagnostic Criteria for Hyperthyroidism
Low TSH
Elevated free and total T3 and T4
Increased radioactive iodine uptake
Treatments for Hyperthyroidism
Anti-thyroid medications Radioactive Iodine (RAI) Thyroidectomy Symptomatic treatment Beta- blockers
Anti-Thyroid Medications
Preferred: methimazole, propylthiouracil (PTU)
Methimazole: first line
PTU: thyroid storm or 1st trimester
Less common: iodine, lithium
Thioamides Predictor of successful therapy
High likelihood of achieving remission
Elderly with low life expectancy and high surgical risk
Nursing home or long term care resident or unable to follow radiation safety guidelines
Lack of access to experience surgeon
h/o neck surgery/radiation
h/o Graves’ opthalompathy
Predictors of Remission (means you would choose thioamides)
Small goiter
Mild disease
Low or negative thyroreceptor antibody titer
Thioamides MOA
Inhibits thyroid hormone synthesis
PTU only: inhibits peripheral T4 to T3 conversion within in hours of dosing
In vivo effect: depletion of stored hormone and prevention of new hormone synthesis
Thioamides Pregnancy and Lactation
Crosses placenta Increased TSH and Decreased T4 in fetus PTU preferred Compatible with breastfeeding Methimazole preferred
Methimazole Dosing
Initial Continue x 4-8 weeks then taper Mild: 15 mg/day Moderate: 30-40 mg/day Severe: 60 mg/day Maintenance 5-30 mg/ day in 1-3 divided doses Initial 1-3 divided doses
Propylthiouracil (PTU) Dosing
Initial 1-3 divided doses 300-450 mg/day Maintenance 100-150 mg/day Thyrotoxic crisis 200 mg Q4-6 hours on Day 1 Taper to maintenance once symptoms disappear
Pharmacokinetics and Dynamics of Thioamides
Absorption Well absorbed from GI tract Peak: 1 hour Distribution Concentrates in thyroid Protein binding: 80% (PTU) Metabolism Liver Elimination Renal, mostly as metabolites Half life: 5-13 hours (methimazole), 1-2 hours (PTU)
Attaining Remission
Continue x 12-18 months
Then taper or d/c if euthyroid at that time
20-30% of patient achieve remission after initial therapy
Remission: normal TSH, FT4, and T3 one year after d/c of antithyroid medication
Follow-up
Re-test every 1-3 months for 6-12 months after initial remission and d/c of methimazole
Failure to maintain remission
Radioactive iodine or thyroidectomy
Minor Adverse Effects of Thioamides
GI upset
Arthralgia
Rash, urticaria, pruritis
5-6% of patients
Severe reactions: treat with 1 mg/kg/day prednisone and d/c therapy
Mild: symptoms likely to resolve on own
Agranulocytosis
Severe Adverse Effect of Thioamides More likely in First 2 months Higher doses Age >40 yo 0.2-0.5% incidence Granulocyte count <250/mm3 Fever, sore throat, bleeding , bruising, malaise, stomatitis Stop drug, administer broad spectrum antibiotics